- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01206348
Combination Treatment for Moderate to Severe Acne
November 28, 2011 updated by: Medicis Global Service Corporation
A Phase IV, Open-Label Study Evaluating the Use of Solodyn (Minocycline HCL Extended-Release Tablets), Ziana, and Triaz Foaming Cloths as Combination Acne Therapy Prior to Treatment With Isotretinoin
To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.
Study Type
Interventional
Enrollment (Actual)
97
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States
-
-
California
-
Santa Monica, California, United States
-
-
Delaware
-
Hockessin, Delaware, United States
-
-
Massachusetts
-
Chestnut Hill, Massachusetts, United States
-
-
Michigan
-
Detroit, Michigan, United States
-
-
Nevada
-
Henderson, Nevada, United States
-
-
North Carolina
-
High Point, North Carolina, United States
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States
-
-
Tennessee
-
Nashville, Tennessee, United States
-
-
Utah
-
Salt Lake City, Utah, United States
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 30 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)
Exclusion Criteria:
- pregnancy and allergies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Open Label Combination
Solodyn, Ziana, Triaz FC
|
Solodyn 1 tablet, Q day Ziana Gel, topical Q am Triaz FC, topical Q night
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Proportion of patients showing improvement from Baseline and Week 12
Time Frame: Week 12
|
Week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Mary Sanstead, BSN, CCRP, Medicis Global Service Corporation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (ACTUAL)
July 1, 2011
Study Completion (ACTUAL)
July 1, 2011
Study Registration Dates
First Submitted
September 17, 2010
First Submitted That Met QC Criteria
September 20, 2010
First Posted (ESTIMATE)
September 21, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
November 30, 2011
Last Update Submitted That Met QC Criteria
November 28, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Skin Diseases
- Acneiform Eruptions
- Sebaceous Gland Diseases
- Acne Vulgaris
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Enzyme Inhibitors
- Antineoplastic Agents
- Dermatologic Agents
- Anti-Bacterial Agents
- Protein Synthesis Inhibitors
- Keratolytic Agents
- Clindamycin
- Clindamycin palmitate
- Clindamycin phosphate
- Benzoyl Peroxide
- Tretinoin
- Minocycline
Other Study ID Numbers
- MP-0104-28
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acne
-
CLASSYS Inc.Not yet recruitingAcne Scars | Acne Scarring | Acne Scar | Acne Scars - AtrophicChina
-
ProgenaBiomeWithdrawnAcne Vulgaris | Acne | Acne Rosacea | Acne Inversa | Acne Keloidalis | Acne Keloid | Acne Conglobata | Acne Cystic | Acne Pomade | Acne Indurata | Acne Papular | Acne Tropica | Acne Urticata | Acne Fulminans | Acne Follicular | Acne Tropicalis | Acne Detergicans | Acne Iodide | Acne VarioliformisUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompletedAcne Scar | Acne Scars - AtrophicChina
-
First Affiliated Hospital of Chongqing Medical...CompletedAcne Scars | Acne ScarringChina
-
Technische Universität DresdenUnknown
-
Chulalongkorn UniversityCompletedPost - Adolescence AcneThailand
-
National Yang Ming UniversityTaipei City HospitalUnknown
-
Ulthera, IncCompleted
-
DarierUnknown
-
Sheikh Zayed Medical CollegeCompletedAtrophic Acne Scarring | Atrophic Acne ScarPakistan
Clinical Trials on Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide
-
Zeichner, Joshua, M.D.Unknown
-
Zeichner, Joshua, M.D.UnknownAcne VulgarisUnited States
-
Padagis LLCCompleted
-
SanofiCompleted
-
Padagis LLCCompleted
-
Padagis LLCCompleted
-
Glenmark Pharmaceuticals Ltd. IndiaCompletedAcne VulgarisUnited States, Belize
-
Stiefel, a GSK CompanyGlaxoSmithKlineCompleted
-
Watson Laboratories, Inc.Completed
-
Bausch Health Americas, Inc.Completed